Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
FeaturedActive & Responsive

Cardiovascular Disease Studies for Adults With High Blood Pressure, High Cholesterol, AFib, or Heart Failure

for
Cardiovascular Diseases, Heart Failure, Atrial Fibrillation,
Location: Brooklyn NY, Morehead City NC, Suffolk VA, New Bern NC,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

High Blood Pressure Studies for Adults Whose Blood Pressure Stays High Despite Two or More Medications

for
Hypertension
Location: Suffolk VA, Charleston SC, Monroe NC,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

Investigational Oral GLP-1 Pill Studies in Canada for Adults With Type 2 Diabetes on Daily Insulin or With Heart Risk

for
Diabetes Mellitus, Type 2, Cardiovascular Diseases
Location: Joliette, Montreal, Stouffville, Toronto, Brampton,

Sex: All

Age: 18+

Recruiting
FeaturedActive & Responsive

Investigational Oral GLP-1 Pill Study for Adults With Type 2 Diabetes and Heart Disease or Heart Risk Factors

for
Diabetes Mellitus, Type 2, Cardiovascular Diseases
Location: Bridgeport CT, Philadelphia PA, Norfolk VA,

Sex: All

Age: 18+

Recruiting
Active & Responsive

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD),
Location: Boston MA, Providence RI, Charleston SC, Greensboro NC,
Sponsor: Pulmovant, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07333183

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

for
Heart Failure, Heart Diseases, Cardiovascular Diseases,
Location: Portland ME, Boston MA, Manhasset NY, The Bronx NY,
Sponsor: Abbott Medical Devices

Sex: All

Age: 18+

Code: NCT06526195

Recruiting
Active & Responsive

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

for
Pulmonary Disease, Pulmonary Hypertension
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All

Age: 18 - 70+

Code: NCT01730092

Recruiting
Active & Responsive

Rutgers University Study of the Genetics of Pulmonary Hypertension

for
Pulmonary Hypertension, Pulmonary Arterial Hypertension,
Location: Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 18+

Code: NCT07217522

Recruiting
Active & Responsive

Pulmonary Hypertension Biorepository and Registry

for
Pulmonary Hypertension, Pulmonary Arterial Hypertension,
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT04808596

Recruiting
Active & Responsive

Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure

for
Heart Failure With Reduced Ejection Fraction,
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT06299436

Recruiting
Active & Responsive

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

for
Pulmonary Hypertension, Interstitial Lung Disease (ILD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT06911632

Recruiting
Active & Responsive

Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)

for
CTEPH
Location: Murray UT
Sponsor: Intermountain Health Care, Inc.

Sex: All

Age: 18+

Code: NCT06105242

Recruiting
Active & Responsive

Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

for
Lung Transplant, Pulmonary Hypertension
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70+

Code: NCT06770023

Phase 1, Recruiting
Active & Responsive

Feasibility Trial for a Right Ventricular Failure Platform Trial

for
Pulmonary Hypertension, Right Ventricular Dysfunction,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06570473

Phase 2, Recruiting
Active & Responsive

MedlyPeds Feasibility Study

for
Pediatric Heart Failure, Congenital Heart Disease (CHD),
Location: Toronto
Sponsor: The Hospital for Sick Children

Sex: All

Age: 8 - 18

Code: NCT07556185

Recruiting
Active & Responsive

Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

for
Hypertension, Pulmonary,
Location: Norfolk VA, Springfield IL, O'Fallon IL
Sponsor: Eko Devices, Inc.

Sex: All

Age: 18+

Code: NCT07087613

Recruiting
Active & Responsive

Global Paradise System US Post Approval Study

for
Hypertension, Cardiovascular Diseases, Vascular Diseases
Location: Boston MA, Stony Brook NY, Bridgeport CT, Brooklyn NY,
Sponsor: ReCor Medical, Inc.

Sex: All

Age: 18+

Code: NCT06297291

Recruiting
Active & Responsive

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

for
Hypertension, Cardiovascular Diseases
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 35 - 65

Code: NCT04715022

Phase 1, Phase 2, Recruiting
Active & Responsive

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: Halifax, Moncton, Methuen MA, Riverhead NY, Hamden CT,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase 3, Recruiting
Active & Responsive

CARBON: UAB Cardiovascular Research Biobank

for
Natriuretic Peptides, Cardiovascular Diseases, Hypertension,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT05067231

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial